CoChat

Metformin: an old therapy that deserves a new indication for the treatment of obesity.

Igel, L. I., Sinha, A., Saunders, K. H., Apovian, C. M., Vojta, D., Aronne, L. J. · 2016 · Current Atherosclerosis Reports

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

Metformin is not currently used for weight loss or diabetes prevention because it lacks an FDA indication for obesity and/or pre-diabetes treatment. Based on the evidence, metformin has been shown to decrease the incidence of type 2 diabetes, and compares favorably to other weight-loss medications in terms of efficacy as well as safety. Thus, metformin should be considered for a treatment indication in patients with these conditions.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11883-016-0568-3

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 62 references

Research works printed but not linked: 1

  1. Centers for Disease Control and Prevention. National Diabetes Statistics Report: estimates of diabetes and its burden in the United States, 2014. Atlanta: U.S. Department of Health and Human Services; 2014.

Cited by

See all 56

Metadata

Authors
Igel, L. I., Sinha, A., Saunders, K. H., Apovian, C. M., Vojta, D., & Aronne, L. J.
Affiliations
  • Weill Cornell Medicine (US)
  • Weill Cornell Medical Center (US)
  • Boston University (US)
  • UnitedHealth Group (United States) (US)
Corresponding author
Igel, L. I.
Venue
Current Atherosclerosis Reports
Published
2016-02-18
Volume
18
Issue
4
Pages
16-16
ISSN
  • 1523-3804 (ISSN-L)
  • 1534-6242
OpenAlex
W2284555808
Cited by
52
References
62
Citations by year
2026: 1 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 4 · 2019: 5 · 2018: 10 · 2017: 10 · 2016: 3
FWCI
1.07
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Current Atherosclerosis Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
metformin, obesity, weight loss, type 2 diabetes prevention, prediabetes, anti-obesity drugs, drug repurposing
MeSH terms
Cardiovascular Diseases, Diabetes Mellitus, Humans, Metformin, Neoplasms, Obesity, Weight Loss, Anti-Obesity Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin: an old therapy that deserves a new indication for the treatment of obesity. https://app.cochat.ai/papers/10.1007/s11883-016-0568-3
The paper
Igel, L. I., Sinha, A., Saunders, K. H., Apovian, C. M., Vojta, D., & Aronne, L. J. (2016). Metformin: an old therapy that deserves a new indication for the treatment of obesity. Current Atherosclerosis Reports. https://doi.org/10.1007/s11883-016-0568-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.